nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0706	0.0706	CcSEcCtD
Remifentanil—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.059	0.059	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0469	0.0469	CcSEcCtD
Remifentanil—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0388	0.0388	CcSEcCtD
Remifentanil—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0358	0.0358	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0358	0.0358	CcSEcCtD
Remifentanil—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0333	0.0333	CcSEcCtD
Remifentanil—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0322	0.0322	CcSEcCtD
Remifentanil—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0275	0.0275	CcSEcCtD
Remifentanil—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0273	0.0273	CcSEcCtD
Remifentanil—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Remifentanil—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.022	0.022	CcSEcCtD
Remifentanil—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0207	CcSEcCtD
Remifentanil—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0197	CcSEcCtD
Remifentanil—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0189	CcSEcCtD
Remifentanil—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0189	CcSEcCtD
Remifentanil—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0188	CcSEcCtD
Remifentanil—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Remifentanil—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Remifentanil—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0145	CcSEcCtD
Remifentanil—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Remifentanil—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Remifentanil—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Remifentanil—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Remifentanil—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Remifentanil—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Remifentanil—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Remifentanil—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Remifentanil—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Remifentanil—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Remifentanil—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Remifentanil—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Remifentanil—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00997	0.00997	CcSEcCtD
Remifentanil—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00991	0.00991	CcSEcCtD
Remifentanil—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00967	0.00967	CcSEcCtD
Remifentanil—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00948	0.00948	CcSEcCtD
Remifentanil—Cough—Hydrochlorothiazide—nephrolithiasis	0.00941	0.00941	CcSEcCtD
Remifentanil—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Remifentanil—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00898	0.00898	CcSEcCtD
Remifentanil—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00887	0.00887	CcSEcCtD
Remifentanil—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0088	CcSEcCtD
Remifentanil—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0088	CcSEcCtD
Remifentanil—Shock—Hydrochlorothiazide—nephrolithiasis	0.00866	0.00866	CcSEcCtD
Remifentanil—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00862	0.00862	CcSEcCtD
Remifentanil—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00859	0.00859	CcSEcCtD
Remifentanil—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00851	0.00851	CcSEcCtD
Remifentanil—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00822	0.00822	CcSEcCtD
Remifentanil—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0079	CcSEcCtD
Remifentanil—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Remifentanil—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00782	CcSEcCtD
Remifentanil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00775	0.00775	CcSEcCtD
Remifentanil—Pain—Hydrochlorothiazide—nephrolithiasis	0.00753	0.00753	CcSEcCtD
Remifentanil—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00753	0.00753	CcSEcCtD
Remifentanil—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00725	CcSEcCtD
Remifentanil—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00699	CcSEcCtD
Remifentanil—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00696	CcSEcCtD
Remifentanil—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00648	0.00648	CcSEcCtD
Remifentanil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00623	CcSEcCtD
Remifentanil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00602	CcSEcCtD
Remifentanil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00582	CcSEcCtD
Remifentanil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0056	0.0056	CcSEcCtD
Remifentanil—Rash—Hydrochlorothiazide—nephrolithiasis	0.00555	0.00555	CcSEcCtD
Remifentanil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00554	CcSEcCtD
Remifentanil—Headache—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00551	CcSEcCtD
Remifentanil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00523	CcSEcCtD
